Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07036367 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Use of Sublingual Melatonin Premedication in Geriatric Cataract Surgery

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated January 7, 2026 (before its estimated May 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 1 to 2
    • Primary completion date: Dec 15, 2025 to May 15, 2026
    • Study completion date: Dec 15, 2025 to Jun 15, 2026
    • Start date changed from estimate of Jul 1, 2025 to Sep 1, 2025
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Al-Azhar University
212 trials monitored
See 3 trials at risk
Anxiety
3,263 trials monitored
See 159 trials at risk
Cataract surgery is routinely performed with anesthesia care, whereas anesthesia care for other elective, low-risk, outpatient procedures is applied more selectively. We hypothesize that sublingual melatonin will provide superior anxiolysis and sedation while maintaining a high safety profile and minimizing hemodynamic disturbances.
Trial Details
NCT Number NCT07036367
Lead Sponsor Al-Azhar University
Conditions
(from sponsor)		 Cataract Surgery Anesthesia
Related terms Anxiety Disorders
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov